Send us Feedback

EpiCept (EPCT)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW

EPCT » Topics » Item 9.01 Financial Statement and Exhibits.

This excerpt taken from the EPCT 8-K filed Jun 23, 2008.

Item 9.01 Financial Statement and Exhibits.

(d) Exhibits.

 

10.1

 

Form of Securities Purchase Agreement.

10.2

 

Form of Warrant.

10.3

 

Placement Agent Agreement, dated May 28, 2008.

10.4

 

Preliminary Prospectus Supplement.

10.5

 

Second Amendment to Loan and Security Agreement, by and among EpiCept Corporation, Maxim Pharmaceuticals Inc. and Hercules Technology Growth Capital, Inc., dated as of June 23, 2008.

10.6

 

Common Stock Warrant, by and between EpiCept Corporation and Hercules Technology Growth Capital, Inc., dated as of June 23, 2008.

99.1

 

Press release, dated June 23, 2008.

 

 

2

 


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

 

EPICEPT CORPORATION 

 

 

 

 

By: 


/s/ Robert W. Cook

 

 

 

 

Name: 

Robert W. Cook

 

 

 

 

Title: 

Chief Financial Officer

Date: June 23, 2008

 

 


EXHIBIT INDEX

 

No.

 

Description

10.1

 

Form of Securities Purchase Agreement.

10.2

 

Form of Warrant.

10.3

 

Placement Agent Agreement, dated May 28, 2008.

10.4

 

Preliminary Prospectus Supplement.

10.5

 

Second Amendment to Loan and Security Agreement, by and among EpiCept Corporation, Maxim Pharmaceuticals Inc. and Hercules Technology Growth Capital, Inc., dated as of June 23, 2008.

10.6

 

Common Stock Warrant, by and between EpiCept Corporation and Hercules Technology Growth Capital, Inc., dated as of June 23, 2008.

99.1

 

Press release, dated June 23, 2008.

 

 

"Item 9.01 Financial Statement and Exhibits." elsewhere:

Cyclacel Pharmaceuticals (CYCC)
Neogen (NEOG)
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki